prikaz prve stranice dokumenta Intersticijska bolest pluća (IBP) u sistemskoj sklerozi (SSc)
  Download
PDF 432.34 KB
Professional paper - Conference paper
Intersticijska bolest pluća (IBP) u sistemskoj sklerozi (SSc)
Reumatizam, 57 (2010), 2; 105-108. urn:nbn:hr:184:249792
Novak, Srđan

Cite this document

Novak, S. (2010). Intersticijska bolest pluća (IBP) u sistemskoj sklerozi (SSc). Reumatizam, 57. (2), 105-108. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:249792

Novak, Srđan. "Intersticijska bolest pluća (IBP) u sistemskoj sklerozi (SSc)." Reumatizam, vol. 57, no. 2, 2010, pp. 105-108. https://urn.nsk.hr/urn:nbn:hr:184:249792

Novak, Srđan. "Intersticijska bolest pluća (IBP) u sistemskoj sklerozi (SSc)." Reumatizam 57, no. 2 (2010): 105-108. https://urn.nsk.hr/urn:nbn:hr:184:249792

Novak, S. (2010) 'Intersticijska bolest pluća (IBP) u sistemskoj sklerozi (SSc)', Reumatizam, 57(2), pp. 105-108. Available at: https://urn.nsk.hr/urn:nbn:hr:184:249792 (Accessed 12 December 2024)

Novak S. Intersticijska bolest pluća (IBP) u sistemskoj sklerozi (SSc). Reumatizam [Internet]. 2010 [cited 2024 December 12];57(2):105-108. Available at: https://urn.nsk.hr/urn:nbn:hr:184:249792

S. Novak, "Intersticijska bolest pluća (IBP) u sistemskoj sklerozi (SSc)", Reumatizam, vol. 57, no. 2, pp. 105-108, 2010. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:249792. [Accessed: 12 December 2024]

Please login to the repository to save this object to your list.
Metadata
Title (croatian)Intersticijska bolest pluća (IBP) u sistemskoj sklerozi (SSc)
Title (english)Interstitial lung disease (ILD) in systemic sclerosis (SSc)
AuthorSrđan Novak
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (croatian)
Intersticijska bolest pluća je česta komplikacija sistemske skleroze koja nerijetko ima lošu prognozu te je zajedno s plućnom arterijskom hipertenzijom najčešći uzrok smrti u ovoj bolesti. U otkrivanju i praćenju iste, najvažnije metode su CT visoke rezolucije te funkcionalni testovi plućne funkcije. Odluka o započinjanju liječenja često je vrlo teška. Kandidati za imunosupresivno liječenje su obično bolesnici u kojih sistemska bolest kratko traje i u kojih dolazi do naglog pada DCO. Kao lijek izbora najčšće se spominje cikolofosfamid primjenjen intavavenski u mjesečnim intervalima zajedno s malim dozama glukokortikoida iako se u liječenju primjenjuju i drugi imunosupresivi, najčešće azatioprin ili mikofenolat mofetil.
Abstract (english)
Intersitial lung disease is a frequent complication of systemic sclerosis that often has a poor pognosis and together with pulmonary arterial hypertension are the most common cause of death in scleroderma patients. For detection and evaluation of interstitial lung disease, high-resolution CT and pulmorary functional tests are pivotal. The decision about whether to start treatment is often the most difficult challenge. Patients with short duration of systemic disease with recent deterioration in DCO are the candidates for immunosupressive therapy. Best current initial treatment is intravenous monthly cyclophosphamide together with low-dose oral glucocorticoids although azathioprine and mycophenolate mofetil are also widelly used.
Keywords (croatian)
Keywords (english)
Languagecroatian
Languageenglish
Publication typeProfessional paper - Conference paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleReumatizam
Numberingvol. 57, no. 2, pp. 105-108
p-ISSN0374-1338
e-ISSN2459-6159
URN:NBNurn:nbn:hr:184:249792
Publication2010
Document URLhttps://hrcak.srce.hr/124633
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2022-09-23 06:43:37